Comparative analysis of the clinical efficacy and reproductive outcomes of the hysteroscopic tissue removal system (MyoSure) and hysteroscopic electroresection in the treatment of benign intrauterine lesions

被引:12
|
作者
Yong, Jiahui [1 ,2 ]
Wan, Yajun [1 ]
Ye, Mingzhu [1 ]
Yi, Shuijing [1 ]
Zeng, Fei [1 ]
Sun, Xin [1 ]
Song, Jiarui [1 ]
Wang, Xinyu [1 ]
Zeng, Xiangyang [1 ]
Xiao, Songshu [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Dept Gynecol & Obstet, Changsha, Peoples R China
[2] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Cardiol, Urumqi, Xinjiang, Peoples R China
[3] Cent South Univ, Xiangya Hosp 3, Dept Gynecol & Obstet, Changsha 410013, Hunan, Peoples R China
关键词
endometrial polyps; hysteroscopic electroresection; MyoSure hysteroscopic tissue removal system; reproductive outcome; retained products of conception; submucous leiomyoma; RETAINED PRODUCTS; CONCEPTION; FIBROIDS; POLYPS; MORCELLATION; MANAGEMENT;
D O I
10.1002/ijgo.14863
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectiveTo compare and analyze the clinical efficacy and reproductive outcomes of the hysteroscopic tissue removal system (MyoSure) and hysteroscopic electroresection in the treatment of benign intrauterine lesions in women of reproductive age. MethodsThis is a retrospective study of patients with benign intrauterine lesions treated with MyoSure or hysteroscopic electroresection. The primary outcomes were operative time and resection completeness, and reproductive outcomes were followed up and compared. Secondary outcomes included perioperative adverse events and postoperative adhesions seen during second-look hysteroscopy. Data analysis was performed using chi(2) and Fisher tests for qualitative variables and Student t-test for quantitative variables. ResultsThe operative times of patients with type 0 or I myoma, endometrial polyps, or retained products of conception in the MyoSure group were shorter than those in the electroresection group but were not significantly different for patients with type II myomas. The complete resection rate was lower in the MyoSure group than in the electroresection group. The degree of decrease in the American Fertility Society score of intrauterine adhesion in the MyoSure group was significantly higher (2.90 +/- 1.29 points vs 1.31 +/- 0.89 points, P = 0.025). The time to pregnancy and the pregnancy rate were higher in the MyoSure group (13.14 +/- 7.85 months vs 16.26 +/- 8.22 months, P = 0.040; 65.12% vs 54.55%, P = 0.045), but there was no significant difference in the term live birth rate, premature birth rate, or abortion rate between the two groups. ConclusionMyoSure has advantages of a shortened operative time and improvement in reproductive outcomes such as pregnancy rate. However, for type II myomas, MyoSure has limitations, and a comprehensive evaluation before the procedure is required.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 28 条
  • [1] Clinical analysis of the MyoSure hysteroscopic tissue removal system of endometrial polyps in women with an intact hymen
    Yong, Jiahui
    Guo, Xiaohui
    Lan, Hua
    Yuan, Jing
    Zeng, Da
    Zeng, Xiangyang
    Yi, Shuijing
    Xiao, Songshu
    BMC WOMENS HEALTH, 2021, 21 (01)
  • [2] Clinical analysis of the MyoSure hysteroscopic tissue removal system of endometrial polyps in women with an intact hymen
    Jiahui Yong
    Xiaohui Guo
    Hua Lan
    Jing Yuan
    Da Zeng
    Xiangyang Zeng
    Shuijing Yi
    Songshu Xiao
    BMC Women's Health, 21
  • [3] Clinical evaluation of improved MyoSure hysteroscopic tissue removal system for the resection of type II submucosal myomas
    Liang, Yufei
    Ren, Yuefang
    Wan, Zeqiu
    Guo, Lihua
    Dong, Jie
    Chen, Yun
    Lv, Liping
    MEDICINE, 2017, 96 (50)
  • [4] Hysteroscopic Tissue Removal System (MyoSure®) in office-setting: an observational study of 187 cases
    Korrapati, S.
    Pervaiz, Z.
    Ewies, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 : 57 - 57
  • [5] Clinical outcomes following hysteroscopic treatment of severe intrauterine adhesions.
    Abu-Rafea, B
    Vilos, GA
    Hollett-Caines, J
    FERTILITY AND STERILITY, 2005, 84 : S473 - S473
  • [6] Hysteroscopic tissue removal systems for the treatment of intrauterine pathology: a systematic review and meta-analysis
    Yin, X.
    Cheng, J.
    Ansari, Sh
    Campo, R.
    Di, W.
    Li, W.
    Bigatti, G.
    FACTS VIEWS AND VISION IN OBGYN, 2018, 10 (04): : 207 - 213
  • [7] Conservative cesarean scar pregnancy treatment: local methotrexate injection followed by hysteroscopic removal with hysteroscopic tissue removal system
    Casadio, Paolo
    Ambrosio, Marco
    Verrelli, Ludovica
    Salucci, Paolo
    Arena, Alessandro
    Seracchioli, Renato
    FERTILITY AND STERILITY, 2021, 116 (05) : 1417 - 1419
  • [8] Effectiveness of a hysteroscopic tissue removal system device for hysteroscopic myomectomy on patients' quality of life: a randomized clinical trial
    Tam, Teresa
    Juarez, Lourdes
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [9] Effectiveness of a hysteroscopic tissue removal system device for hysteroscopic myomectomy on patients’ quality of life: a randomized clinical trial
    Teresa Tam
    Lourdes Juarez
    BMC Women's Health, 23
  • [10] Comparative Efficacy of NovaSure, the Levonorgestrel-Releasing Intrauterine System, and Hysteroscopic Endometrial Resection in the Treatment of Menorrhagia: A Randomized Clinical Trial
    Ghazizadeh, Shirin
    Panahi, Zahra
    Ghanbari, Zinat
    Menshadi, Azam Tarafdari
    Farahmandian, Tahere
    Javadian, Pouya
    JOURNAL OF GYNECOLOGIC SURGERY, 2014, 30 (04) : 215 - 218